October 02 - 03, 2025
Sheraton San Diego Hotel & Marina, San Diego, CA

Pushing Traditional Boundaries in Pharmaceutical Science by Accelerating the Discovery & Development of Novel Therapeutics

October 02 - 03, 2025
Sheraton San Diego Hotel & Marina, San Diego, CA, USA

Explore Discovery & Development US 2025: Guiding Biopharma From Target Identification To Clinical Candidate

  • Connect & collaborate with 1000+ leaders in biology and chemistry at the renowned Discovery & Development US Summit in San Diego, where we provide a platform to help you make informed pipeline decisions in early R&D & accelerate the route from target identification to novel clinical candidate, ultimately increasing the number of life-saving treatments for those with critical illnesses.
  • Together with Formulation & Delivery & Automation & Robotics, benefit from an event supporting you to identify potential formulation & delivery bottlenecks and issues before they arise and promoting collaboration to ensure the development of optimised drug products.
Discovery Development Exhibition Hall

Explore the Discovery & Development Europe 2025 Programme

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

D&D About Square Button

About

Discover more about our ecosystem of channels for the discovery R&D community

Biologics US Attend Square

Attend

Be part of the new wave of development R&D innovation

Partner Image

Partner

Showcase your offering to leading pharma and biotech decision makers

Biom & Pre Med Whats On Image

What's On

Explore dynamic panels, engaging roundtables, and hands-on workshops

Discovery & Development Europe 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration in Drug Discovery, Formulation and Delivery including: 

Drug Discovery & Automation Programme - Key Themes

Panel Discussion: Technological Advancements For Novel Target Discovery

  • Application of new technologies in identifying therapeutics for novel or currently undruggable targets
  • Utilising AI/ML
  • Challenges & future opportunities

 

Panellists include Giovanni Spagnolli, Chief Technology Officer, Sibylla Biotech, Ian Roberts, Senior Director, Digital Biology, Healx & Zoran Rankovic, Director, Center for Protein Degradation, The Institute of Cancer Research

Panel Discussion: Novel Platforms & Techniques To Improve Hit Identification

 

•    Optimising Hit discovery
•    Minimising false positives
•    Integration of techniques

 

Moderated by Jonathan Hopper, Vice President Platforms & Founder, OMass Therapeutics

Panel Discussion: Fostering Partnerships & Collaboration In 2025 – as part of our newly introduced Early-Stage R&D Innovation Programme

 

  • Emerging technologies & techniques
  • Cross-sector partnership
  • Open innovation

 

Moderated by Alexander Natz, Secretary General, EUCOPE & panellists from Cicio Holdings, BioAge Labs, European Commission, Pfizer & Business Region Gothenburg

Panel Discussion: Breakthrough Biotech: How Research Leaders Fund The Next Big Idea

 

  • How research leaders identify and support fundable biotech innovations
  • Overcoming early-stage funding gaps in biotech startups
  • The role of research partnerships with pharma, VCs, and industry in startup success
  • What startups can learn from research-backed biotech wins

 


Panellists include Christoph Rösli, Director of Research Bern, CSL Behring & Member of the Selection Board, BaseLaunch; David Jenkinson, Head of Childhood Cancer Translational Challenge, LifeArc; David Dexter, Director of Research, Parkinsons UK 

Fireside Chat: Impact of AI & Big Data in Drug Discovery & Development

 

Panel Discussion: Translational Studies to Support Better Drug Design

  • Bridging the gap between pre-clinical & clinical research
  • Biomarkers & AI/ML in translational research

 

Moderated by Philippe Marc, Executive Director, Global Head of Integrated Data Sciences, Novartis

Panel Discussion: Fostering Collaboration To Accelerate Neurodegenerative Disease Research


•    Pharma, biotech & academic partnerships
•    The need for innovation, data & technology in CNS research
•    Challenges to be solved through collaboration 

Moderated by Emma Mead, Chief Scientific Officer, Alzheimer’s Research UK Oxford Drug Discovery Institute, University of Oxford. Panellists include Knut Biber, Research Fellow & Head of Glial Biology Team, AbbVie; Sarah Jolly, Principal Scientist, LifeArc; Michael Johnson, Professor of Neurology & Genomic Medicine, Imperial College London


Day 2 Breakfast Workshop - LifeArc: Biomarkers In Neurodegenerative Diseases: From Detection To Progression - Are Blood -Based Biomarkers Enough?

  • Beyond blood-based biomarkers?
  • Are we any closer to a solution?
  • Application of AI/ML

Moderated by Manuela Cerina, Scientific Director – Neurodegeneration, LifeArc & Giovanna Lalli, Director of Strategy & Operations, LifeArc

Panel Discussion:
Automation & Robotics In Drug Discovery & Development – Where Are We Now? 


•    Impact of automation 
•    AI/ML  
•    Robotics in lab processes

Moderated by Rekha Lakshmanan, Global Head of Data Office, AstraZeneca

Panellists include: James Love, Vice President Cross Modalities Workflows, Novo Nordisk, Sarah Trice, COO & Head of US Operations, XtalPi & Tom Kissling, pRED Lab Automation Partner, Roche

Day 2 Breakfast Workshop: SiLA & AnIML Splash


•    Splash! Is a unique event for every digital lab enthusiast. It combines an educational part with a hands-on session to try out standards in action. Pick up the details on the popular SiLA and AnIML standards, understand how they work and where you can put them to use. Our hands-on session lets you experience the standards in action firsthand. We’re bringing real and cloud-based instruments and lots of example data sets 
•    Feel free to bring an instrument or your own data

Formulation and Delivery Programme - Key Themes

Panel Discussion: Moving Beyond Oral Delivery

 

•    Nanoparticles
•    Inhalation
•    Transdermal
•    Developments with Oral Delivery

Moderated by Sandor Batkai, Life Science Consultant, Former, Head of Medical Research and Intelligence, Cardior Pharmaceuticals

Panellists include Shadi Farhangrazi, Chief Executive Officer, S.M. Discovery Group, Joël Richard, Executive Head, Product Development, DBV, Kamalinder Singh, Professor of Pharmaceutical, Technology & Drug Delivery, Karsten Mäder, Professor, Martin Luter University Halle-Wittenberg

Panel Discussion: AI/ML & Novel Technologies In Formulation & Delivery

  • Applications of AI/ML in formulation and delivery
  • AI-driven approaches to optimise dosage forms
  • Novel delivery technologies
  • AI/ML for personalised formulations

 

Moderated by Shilpa Thosar, CMC/Regulatory CMC Executive, Former Executive Director, Cara Therapeutics

Roundtable: Discovery And Delivery Of Therapeutics Across The Blood Brain Barrier – Where Are We Now?

  • Brain shuttle platform
  • Monocytes
  • Microbubbles

 

Moderated by Shadi Farhangrazi, Chief Executive Officer, S.M. Discovery Group

Key Event Highlights

An unmissable journey awaits you: from award winning speakers and insightful workshops to an exclusive gala dinner. Discover the moments that will transform your Discovery & Development experience. 

Who is Speaking at Discovery & Development US 2025?

Aaron Frank
Head of Computational Chemistry,
Arrakis Therapeutics
Andrew Geall
Co-Founder and Chief Development Officer,
Replicate Bioscience Inc
Beth Hoffman
Founder & CEO,
Origami Therapeutics
Bindhu Rayaprolu
Director,
Regeneron
Craig Behnke
Executive Vice President, Production and Development,
Lumen Bioscience Inc
Dimitrios Zisoulis
Head of RNA Therapeutics,
Johnson & Johnson Innovative Medicine
Lauren Goodrich
Head of Platform,
Nimble Therapeutics
Maria Sörhede Winzell
Senior Director,
Camurus
Rajita Pappu
Principal Scientist and Senior Director, Immunology Discovery, Research Biology,
Genentech
Raymond Deshaies
Senior Vice President of Global Research,
Amgen
,
Abhinav Sharma
Translational Human Models Lead,
AbbVie
Ankit Baheti
Lead Scientist, CMC Formulation,
Ferring Pharmaceuticals Pvt. Ltd.
Catherine Cahill
Assistant Professor of Psychiatry,
Harvard University
David Loynd
Chief Executive Officer,
EnduRx Pharmaceuticals Inc.
David Buckler
Executive Director, Research Program Management,
Regeneron
Elena Liang
Principal Research Scientist,
AbbVie
Enrico Zambelli
Sustainable Formulations Unit Manager,
chiesi farmaceutici
Eric Munson
Professor,
Purdue University
Fabien Vincent
Research Fellow Laboratory Head Primary Pharmacology Group (PPG) Discovery Sciences,
Pfizer Ltd
Jack Rogers
Director,
Neurochemistry at Harvard University
Jamie Tsung
Director,
Alnylam Pharmaceuticals
Jason Halladay
Senior Vice President, DMPK/BA/Pharmacology,
Protagonist Therapeutics
Jean Ge
Patent Attorney,
Wolf Greenfield
Jeffrey O'Brien
Sr Scientist,
BMS
Jitendra Kumar
Lead Scientist,
Entos Pharmaceuticals US
Josh Baughman
Scientific Director,
Bristol Myers Squibb
Kalpita Mehta
Combo expert,
Hikma Pharmaceuticals
Kanika Suri
Scientist,
Takeda
Katherin Patsch
Director - Drug Discovery,
Ellison Institute of Technology
Kausheek Nandy
Digital Transformation Director - Research,
Boehringer Ingelheim
Lei Jia
Associate Director,
Johnson & Johnson
Michelle Broggi
Principal Scientist,
Pfizer Ltd
Nagendra Chemuturi
Senior Director, ADME,
Eli Lilly
Peter Heifetz
Chief Executive Officer,
Orpro Therapeutics
Phil Cox
Research Fellow, Augmented Molecular Design, Discovery Platform Technologies,
AbbVie
Prashi Jain
Director, Drug Discovery,
Iterion Therapeutics
Rick Ewing
Vice President,
Rapafusyn Pharmaceuticals
Robert Goodnow
Formerly Head Drug Discovery Sciences,
GoodChem Consulting
Robert Fremeau
Founder and Chief Executive Officer,
BrainStorm Therapeutics, Inc.
Safiye Celik
Associate Director of Data Science,
Recursion
Sam Sinai
Co-Founder, Head of Machine Learning,
Dyno Tx
Sayoni Ray
Principal Scientist,
Johnson & Johnson
Sean Sullivan
Vice President, Technology Innovation and Development,
Arcturus Therapeutics
Severin Schneebeli
Associate Professor,
Purdue University
Shah Nawaz
Chief Digital & Technology Officer & Vice President, Digital Transformation & Engineering,
Regeneron
Shanthi Nagarajan
Director,
Eli Lilly
Shilpa Thosar
Former Director,
Cara Therapeutics
Shouvik Roy
Executive Director,
Merck
Shuangwei Li
Director of Toxicology,
Calibr-Skaggs Institute for Innovative Medicines
Stefano Zanotti
VP, Head of Neuromuscular Research,
Dyne Therapeutics
Stephen Framil
Global Head of Accessibility,
Merck Life Science KGaA
Stephen Turner
Chief Executive Officer,
Pangio Biosystems
Sunita Yadav
Associate Director ,
Novartis Pharma
Surendra Nayak
Scientific Associate Director,
Bristol Myers Squibb
Tobias Raabe
Research Assistant Professor of Medicine,
University of Pennsylvania
Vivek Gupta
Associate Dean,
St. John's University
f9d83b55-ff87-4538-a4e2-f67b63da4765-2-5668375logo-Axion-Logo_Tagline_2022

 

Good number of 1-1 meetings with relevant people. Very happy with the networking process and the Oxford Global team are very nice and service minded.


Regional Sales Director
AxionBio

5a563b71-261f-4b78-a13b-5b4890a6b41d-2-5668375logo-Copy-of-Arctoris-blue-logo-1-Transparent

 

Absolutely outstanding conference attracting large pharma and aspiring biotechs. Oxford Global are excellent, the food is outstanding and the preset meetings are informal and impactful

Vice President of Business Development
Arctoris

Novalix Logo

 

The organisation was perfect. Good mix between excellent scientific presentations and network opportunities.


Pharmacology Associate Director
Novalix

novartis-logo

 

This was my first time at the conference and it was a great experience. Very well organized conference and I learned a lot and made valuable connection - Thank you Oxford Global.


Senior Principal Scientist

Novartis

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Interested in Sponsoring Discovery & Development US 2025?

Become a driving force in accelerating the volume of safe, effective first-in-class drugs to reach patients. Discovery & Development offers a unique platform to enhance your brand visibility and connect with thousands of biopharma decision-makers. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the innovators shaping the future of R&D today

New Opportunities

The Start-up Zone

Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs. 

Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.

For further information and to get started submit the application form below.

 

Criteria:

The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.

To be eligible for inclusion, you must meet the following criteria:

•    0 – 5 years operating
•    0 – 30 employees
•    Pre-Series A funding


What you will receive:

  • 2 full conference passes
  • 10-minute pitch on the Start-Up Stage
  • 1x1m space in Start-Up Zone for own partnering meetings; cocktail table provided, start-up to bring 1x pull-up banner
  • Logo featured on website & event platform as a participating start-up
  • Ability to arrange 1:1 meetings via the congress app

 

2025 Young Scientist Awards (YSA) for Best Poster Presentation

The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.

Please submit your poster presentation by no later than 13th January 2025 in the below category:

  • Protein/Antibody Engineering
  • Bioanalysis & Characterisation
  • Next Generation Biotherapeutics
  • Peptides Chemistry & Therapeutics
  • Oligonucleotides Chemistry & Therapeutics
  • Sustainable Chemistry & Manufacturing
  • Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
  • Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
  • ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows: 

  • Register and submit an abstract by 13th January 2025 using the registration link to the left on this page 
  • Once registered you will be provided with the online abstract submission form 
  • Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.) 
  • The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event 
  • The winners’ 10-minute oral presentations will take place during the networking drinks on day 2 

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights. 

Plan Your Visit

Sheraton San Diego Hotel & Marina
1380 Harbor Island Drive, San Diego
California
USA, 92101

By Air

From San Diego International Airport (SAN), the hotel is just 1.5 miles from the airport.

  • Shuttle: Use the free Sheraton shuttle, available at Terminal 1 & Terminal 2. Look for the “Hotel Courtesy Shuttle” sign.
  • If Shuttle is unavailable: Take the 992 bus from the airport to the Harbor Island Drive & Sheraton Way stop (5-minute ride). Walk 5 minutes to the hotel.

By Tram/Bus

The total journey from downtown via tram and bus should take around 20-30 minutes.

  1. Take the San Diego Trolley:
    Use the Green Line or another line that connects to the Santa Fe Depot station.
  1. Transfer to Bus or Walk:
    From Santa Fe Depot, take Bus 992 (Airport Route) toward the San Diego International Airport. Exit at the hotel stop near Harbor Island.
  • Alternatively, walk approximately 30 minutes (1.5 miles) along Harbor Drive to the hotel.

Ensure to check the trolley and bus schedules for exact timings.

By Car

Directions:
 

Merge onto I-5 North:

  • Exit 17A toward W Hawthorn St toward San Diego Airport
  • Keep left to stay on W Hawthorn St
  • Turn Right onto N Harbor Drive
  • Follow N Harbor Drive until you reach Harbor Island Drive
  • Turn Left onto Harbor Island Drive
  • Sheraton San Diego Resort will be on your right

Merge onto I-5 South:

  • Exit 18A toward Sassafras St/San Diego Airport
  • Turn Right onto W Laurel St
  • Take a slight right onto N Harbor Drive
  • Turn Left onto Harbor Island Drive
  • Sheraton San Diego Resort will be on your right

 

Parking Options:

  • Overnight Self-Parking rate has been discounted to $25.00 per vehicle, and Overnight Valet Parking at $65.00 per vehicle.

  • Event Only Parking is discounted to Self-Parking at $22.00 per vehicle, and Valet Parking at $47.00 per vehicle.

Oxford Global has secured a number of bedrooms at the Sheraton San Diego Hotel & Marina at a reduced conference rate: 

 

  • Wednesday 1st October 2025 – $309 (inclusive of taxes and fees - no breakfast)
  • Thursday 2nd October 2025 – $309 (inclusive of taxes and fees - no breakfast)

A nightly resort charge of $15 is included, providing guests with premium amenities:
High-speed Wi-Fi: Available in guest rooms, public areas, meeting spaces, and F&B outlets
Fitness & Recreation: 24-hour fitness centre access, morning yoga class, and 60-minute tennis court use
Airport Shuttle: Complimentary transportation to and from San Diego International Airport

 

Should you wish to book a room, please email help@oxfordglobal.com

 

The final cut-off date to book bedrooms is Wednesday 3rd September 2025 – any bookings after this date are subject to availability and rates. Please note that any cancellations within 14 days prior to arrival are subject to full cancellation charges.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Discovery & Development US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Interested in Discovery & Development US 2025?